Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for refractory anemia with excess blasts- 1
Most Correlated Studies
- Pediatric myelodysplastic syndrome gene expression profiles associated with disease subtype
- Bone marrow mononuclear cells from patients with myelodysplastic syndrome subtypes
- Mesenchymal stromal cells of myelodysplastic syndrome (MDS) patients - RCMD and RAEB subtypes
- Mesenchymal stromal cells from patients with myelodysplastic syndrome or acute myeloid leukemia
- Gene expression profiling of CEBPA double and single mutant and CEBPA WT AML
Most Relevant Literature
- Plasma protein alterations in the refractory anemia with excess blasts subtype 1 subgroup of myelody…
- Huge multinucleated megaloblasts found in a patient with refractory anemia with excess blasts-1.
- Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythe…
- Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.
- Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring siderobla…
Most Relevant Clinical Trials
- Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidin…
- Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Othe…
- DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Exces…
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
- Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelo…
